Clinical Characteristics, Molecular Phenotyping, and Management of Isolated Adrenal Metastases From Lung Cancer

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107 Walters, 2013, Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007, Thorax, 68, 551, 10.1136/thoraxjnl-2012-202297 Hellman, 1995, Oligometastases, J Clin Oncol, 13, 8, 10.1200/JCO.1995.13.1.8 Niibe, 2010, Oligometastases and oligo-recurrence: the new era of cancer therapy, Jpn J Clin Oncol, 40, 107, 10.1093/jjco/hyp167 Albain, 1991, Survival determinants in extensive-stage non-small cell lung cancer: the Southwest Oncology Group experience, J Clin Oncol, 9, 1618, 10.1200/JCO.1991.9.9.1618 Eberhardt, 2015, The IASLC Lung Cancer Staging Project: proposals for the revision of the M descriptors in the forthcoming eight edition of the TNM classification of lung cancer, J Thorac Oncol, 10, 1515, 10.1097/JTO.0000000000000673 Parikh, 2014, Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 89, 880, 10.1016/j.ijrobp.2014.04.007 Tanvetyanon, 2008, Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis, J Clin Oncol, 26, 1142, 10.1200/JCO.2007.14.2091 Gao, 2017, Pooled analysis for surgical treatment for isolated adrenal metastasis and non-small cell lung cancer, Interact Cardiovasc Thorac Surg, 24, 1, 10.1093/icvts/ivw321 David, 2017, The role of thoracic surgery in the therapeutic management of metastatic non-small cell lung cancer, J Thorac Oncol, 12, 1636, 10.1016/j.jtho.2017.08.008 Mordant, 2012, Which metastasis management allows long-term survival of synchronous solitary M1b non-small cell lung cancer?, Eur J Cardiothorac Surg, 41, 617, 10.1093/ejcts/ezr042 Loi, 2019, Synchronous oligometastatic lung cancer deserves a dedicated management, Ann Thorac Surg, 107, 1053, 10.1016/j.athoracsur.2018.10.029 Legras, 2018, Validity of targeted next-generation sequencing in routine care for identifying clinically relevant molecular profiles in non-small-cell lung cancer: results of a 2-year experience on 1343 samples, J Mol Diagn, 20, 550, 10.1016/j.jmoldx.2018.04.002 Higashiyama, 1994, Surgical treatment of adrenal metastasis following pulmonary resection for lung cancer: comparison of adrenalectomy with palliative therapy, Int Surg, 79, 124 Porte, 1998, Adrenalectomy for a solitary adrenal metastasis from lung cancer, Ann Thorac Surg, 65, 331, 10.1016/S0003-4975(97)01284-8 Mazzella, 2017, Multimodality treatment of oligometastatic non-small cell lung cancer: review of literature, Shanghai Chest, 1, 6, 10.21037/shc.2017.12.06 Howell, 2013, Outcome and prognostic factors after adrenalectomy for patients with distant adrenal metastasis, Ann Surg Oncol, 20, 3491, 10.1245/s10434-013-3050-2 Raz, 2011, Outcomes of patients with isolated adrenal metastasis from non-small cell lung carcinoma, Ann Thorac Surg, 92, 1788, 10.1016/j.athoracsur.2011.05.116 Zhang, 2017, Significant prognostic features and patterns of somatic TP53 mutations in human cancers, Cancer Inform, 16, 10.1177/1176935117691267 Zhao, 2016, EGFR mutation status of paired cerebrospinal fluid and plasma samples in EGFR mutant non-small cell lung cancer with leptomeningeal metastases, Cancer Chemother Pharmacol, 78, 1305, 10.1007/s00280-016-3155-y Frankel, 2018, Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluid, Clin Chem Lab Med, 56, 748, 10.1515/cclm-2017-0527 Li, 2016, Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases, J Neurooncol, 128, 93, 10.1007/s11060-016-2081-5 Schmid, 2009, EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymphnode metastases, Clin Cancer Res, 15, 4554, 10.1158/1078-0432.CCR-09-0089 Correa, 2016, Stereotactic body radiotherapy for oligometastasis: opportunities for biology to guide clinical management, Cancer J, 22, 247, 10.1097/PPO.0000000000000202 Turajlic, 2016, Metastasis as an evolutionary process, Science, 352, 169, 10.1126/science.aaf2784 Collaud, 2012, Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage, Lung Cancer, 78, 234, 10.1016/j.lungcan.2012.09.011 Karolyi, 1990, Do adrenal metastases from lung cancer develop by lymphogenous or hematogenous route?, J Surg Oncol, 43, 154, 10.1002/jso.2930430306 Zerrweck, 2012, Renal origin and size are independent predictors of survival after surgery for adrenal metastasis, Ann Surg Oncol, 19, 3621, 10.1245/s10434-012-2464-6 Formenti, 2009, Systemic effects of local radiotherapy, Lancet Oncol, 10, 718, 10.1016/S1470-2045(09)70082-8 Bobbio, 2015, Immune therapy of non-small cell lung cancer. The future, Pharmacol Res, 99, 217, 10.1016/j.phrs.2015.06.011